Moderna Inc
- Moderna Inc. declined 20% to $33.72 after the biotech company lowered its 2025 revenue range to between $1.5 billion and $2.5 billion, a decrease of $1 billion from the previous estimate as the company continues its operating costs.
The revised outlook is lower than the previous outlook between $2.5 billion and $3.5 billion issued in September.
Jan 13, 2025
If you want to see the full data, please log in to your account. Logging in gives you complete access to all available information, features, and detailed insights that are not visible to guest users.